Cargando…

Association of Increased Prostate-Specific Antigen Levels After Treatment and Mortality in Men With Locally Advanced vs Localized Prostate Cancer: A Secondary Analysis of 2 Randomized Clinical Trials

IMPORTANCE: Increased prostate-specific antigen (PSA) levels after treatment (PSA failure) may have different associations with outcomes for men with locally advanced vs localized prostate cancer. OBJECTIVE: To evaluate whether the association between PSA failure and death may be different in locall...

Descripción completa

Detalles Bibliográficos
Autores principales:	King, Martin T., Chen, Ming-Hui, Collette, Laurence, Neven, Anouk, Bolla, Michel, D’Amico, Anthony V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129819/ https://www.ncbi.nlm.nih.gov/pubmed/33999161 http://dx.doi.org/10.1001/jamanetworkopen.2021.11092

Ejemplares similares

Risk of Short-Term Prostate-Specific Antigen Recurrence and Failure in Patients With Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial
por: Sayan, Mutlay, et al.
Publicado: (2023)

Prior-Cancer Diagnosis in Men with Nonmetastatic Prostate Cancer and the Risk of Prostate-Cancer-Specific and All-Cause Mortality
por: Mirabeau-Beale, Kristina, et al.
Publicado: (2014)

Natural History of Untreated Prostate Specific Antigen Radiorecurrent Prostate Cancer in Men with Favorable Prognostic Indicators
por: Martin, Neil E., et al.
Publicado: (2014)

Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis
por: Ma, Ting Martin, et al.
Publicado: (2021)

The role of radiotherapy in localised and locally advanced prostate cancer
por: Bolla, Michel, et al.
Publicado: (2019)

Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer–Specific Mortality
por: Burgess, Laura, et al.
Publicado: (2022)

Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels: A Meta-Analysis
por: Mahal, Brandon A., et al.
Publicado: (2023)

Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial
por: Shore, Neal D., et al.
Publicado: (2022)

Surgical Delay and Pathological Outcomes for Clinically Localized High-Risk Prostate Cancer
por: Xia, Leilei, et al.
Publicado: (2020)

Cost-effectiveness of Robotic-Assisted Radical Prostatectomy for Localized Prostate Cancer in the UK
por: Labban, Muhieddine, et al.
Publicado: (2022)

Assessment of Second Primary Cancer Risk Among Men Receiving Primary Radiotherapy vs Surgery for the Treatment of Prostate Cancer
por: Bagshaw, Hilary P., et al.
Publicado: (2022)

Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance
por: Nelson, Tyler J., et al.
Publicado: (2021)

Urinary Outcomes for Men With High Baseline International Prostate Symptom Scores Treated With Prostate SBRT
por: Gorovets, Daniel, et al.
Publicado: (2020)

Surgery vs. radiotherapy in localized prostate cancer. Which is best?
por: Welz, Stefan, et al.
Publicado: (2008)

Is leisure time sitting associated with mortality rates among men diagnosed with localized prostate cancer?
por: Bonn, Stephanie E., et al.
Publicado: (2020)

Preferences for More or Less Health Care and Association With Health Literacy of Men Eligible for Prostate-Specific Antigen Screening in Australia
por: Pickles, Kristen, et al.
Publicado: (2021)

The older the better: The characteristic of localized prostate cancer in Chinese men
por: Wang, Haifeng, et al.
Publicado: (2015)

Cost-effectiveness of Prostate Radiation Therapy for Men With Newly Diagnosed Low-Burden Metastatic Prostate Cancer
por: Lester-Coll, Nataniel H., et al.
Publicado: (2021)

The Predictive Role of Prostate-Specific Antigen Changes Following Transurethral Resection of the Prostate for Patients with Localized Prostate Cancer
por: Wu, Chun-Te, et al.
Publicado: (2020)

Association of Bone Mineral Density Testing With Risk of Major Osteoporotic Fractures Among Older Men Receiving Androgen Deprivation Therapy to Treat Localized or Regional Prostate Cancer
por: Suarez-Almazor, Maria E., et al.
Publicado: (2022)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
por: Teoh, Jeremy YC, et al.
Publicado: (2017)

Racial and Ethnic Disparities in the Use of Prostate Magnetic Resonance Imaging Following an Elevated Prostate-Specific Antigen Test
por: Abashidze, Nino, et al.
Publicado: (2021)

Low-Value Prostate-Specific Antigen Test for Prostate Cancer Screening and Subsequent Health Care Utilization and Spending
por: Kim, David D., et al.
Publicado: (2022)

Low-Value Prostate-Specific Antigen Screening in Older Males
por: Kalavacherla, Sandhya, et al.
Publicado: (2023)

Sources of Information for Learning and Decision-Making in Men With Localized Prostate Cancer
por: Chhatre, Sumedha, et al.
Publicado: (2020)

Correspondence on “COVID-19 Related Anxiety in Men With Localized Prostate Cancer”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Financial burden of men with localized prostate cancer: a process paper
por: Housten, Ashley J., et al.
Publicado: (2023)

Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death
por: Tilki, Derya, et al.
Publicado: (2023)

Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort
por: Bergengren, Oskar, et al.
Publicado: (2021)

Cost-Effectiveness of Annual Prostate MRI and Potential MRI-Guided Biopsy After Prostate-Specific Antigen Test Results
por: Yun, Hyunkyung, et al.
Publicado: (2023)

Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years: A Secondary Analysis of a Cohort in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
por: Kovac, Evan, et al.
Publicado: (2020)

Normalization of prostate specific antigen in patients treated with intensity modulated radiotherapy for clinically localized prostate cancer
por: Schmitz, Matthew D, et al.
Publicado: (2010)

Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy
por: Pinkawa, Michael, et al.
Publicado: (2012)

Association Between Cardiorespiratory Fitness and Cancer Incidence and Cancer-Specific Mortality of Colon, Lung, and Prostate Cancer Among Swedish Men
por: Ekblom-Bak, Elin, et al.
Publicado: (2023)

Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer: A Randomized Clinical Trial
por: Vaishampayan, Ulka N., et al.
Publicado: (2021)

Defining Prostatic Vascular Pedicle Recurrence and the Anatomy of Local Recurrence of Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography
por: Dundee, Philip, et al.
Publicado: (2022)

Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues.
por: Howarth, D. J., et al.
Publicado: (1997)

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia
por: Putra, Ida Bagus O.W., et al.
Publicado: (2016)

Survival and mortality of elderly men with localized prostate cancer managed with primary androgen deprivation therapy or by primary observation
por: Seikkula, Heikki, et al.
Publicado: (2020)

Geographic Distribution of Racial Differences in Prostate Cancer Mortality
por: Fletcher, Sean A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_89sp14jiitupk1mrf3lmp7lr03